Information:
Error:
Keywords
Routine documentation ×
- Microbiology (7)
- EHR (5)
- Laboratories (5)
- AML (4)
- Communicable Diseases (4)
- Pediatrics (4)
- Leukemia (3)
- Medical History Taking (3)
- Infection (2)
- Neoplasm Staging (2)
- Patient Discharge (2)
- Pneumonia (1)
- Aspergillus (1)
- Virology (1)
- Kidney Transplantation (1)
- Prosthesis-Related Infections (1)
- Stem Cell Transplantation (1)
- Infectious Disease Medicine (1)
- Methicillin-Resistant Staphylococcus aureus (1)
- Child Care (1)
- Clinical Laboratory Services (1)
- Cystic Fibrosis (1)
- Diagnosis (1)
- Dialysis (1)
- Hematology (1)
- Amyloidosis (1)
- Lung (1)
- Lymphoma (1)
- Medical Oncology (1)
- Meningitis (1)
- Multiple Myeloma (1)
- Orthopedics (1)
- Patient Admission (1)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
25 Search results.
Itemgroup: Microbiology findings
Itemgroup: Microbiological findings
Itemgroups: Default Itemgroup, Status, Attending, Admitting Diagnosis, Condition, Allergies, Diet, Activity, Nursing, Medications, IV, Lab, Consult
Itemgroup: Microbiology findings
Itemgroups: Personal Information, Diagnosis, Therapy, Anamnesis, Clinical evaluation, Immunological data
Itemgroups: General information, Nosocomial infection, Microbiological diagnostics, Diagnoses; medical procedures, ICU stay, Antibiotics, Risk factors, Signature
Itemgroups: Patient demographics, Specimen, Assessment, Footer module, Microbiology
Itemgroups: Patient demographics, Specimen, Assessment, Footer module
Itemgroups: Patient demographics, Specimen, Assessment, Footer module
Itemgroups: EBMT FORM GENERAL INFORMATION, PATIENT, DISEASE, PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA), PRE-HSCT TREATMENT, HSCT, STATUS OF DISEASE AT COLLECTION, DISEASE STATUS AT HSCT, ADDITIONAL TREATMENT POST-HSCT, STATUS OF DISEASE AT 100 DAYS AFTER HSCT, FORMS TO BE FILLED IN, PLASMA CELL DISORDERS (INCLUDING MULTIPLE MYELOMA), PATIENT LAST SEEN, GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT, OTHER COMPLICATIONS SINCE LAST REPORT, ADDITIONAL THERAPIES SINCE LAST FOLLOW UP, FIRST EVIDENCE OF RELAPSE OR PROGRESSION SINCE LAST HSCT, LAST DISEASE AND PATIENT STATUS
Itemgroups: GENERAL INFORMATION TEAM, GENERAL INFORMATION PATIENT, DISEASE, AL AMYLOIDOSIS INITIAL DIAGNOSIS, ORGAN INVOLVEMENT AT DIAGNOSIS, PRE-HSCT TREATMENT, HSCT, STATUS OF DISEASE AT COLLECTION (AUTOGRAFTS ONLY), STATUS OF DISEASE AT START OF CONDITIONING FOR BMT, STATUS OF DISEASE AT 100 DAYS AFTER HSCT, ORGAN-SPECIFIC RESPONSES AT 100 DAYS AFTER HSCT, FORMS TO BE FILLED IN, FOLLOW UP AL AMYLOIDOSIS, PATIENT LAST SEEN, GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT, OTHER COMPLICATIONS SINCE LAST REPORT, GRAFT ASSESSMENT AND HAEMOPOIETIC CHIMAERISM, ADDITIONAL THERAPIES SINCE LAST FOLLOW UP, FIRST EVIDENCE OF DISEASE WORSENING SINCE LAST HSCT, LAST DISEASE AND PATIENT STATUS, ADDITIONAL NOTES IF APPLICABLE
Itemgroups: GENERAL INFORMATION, GENERAL INFORMATION, DISEASE, LYMPHOMA, TREATMENT GIVEN BEFORE THE 1ST TRANSPLANT, DISEASE HISTORY BEFORE HSCT, STATUS OF DISEASE AT HSCT, ADDITIONAL TREATMENT POST-HSCT, BEST DISEASE RESPONSE AT 100 DAYS POST-HSCT, FORMS TO BE FILLED IN, LYMPHOMA FOLLOW UP, GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT, OTHER COMPLICATIONS SINCE LAST REPORT, DATE(S) AND RESULTS OF ALL TESTS DONE FOR ALL DONORS, ADDITIONAL THERAPIES SINCE LAST FOLLOW UP, FIRST EVIDENCE OF RELAPSE OR PROGRESSION SINCE LAST HSCT, ADDITIONAL NOTES IF APPLICABLE